Quality of life after acute myocardial infarction among patients treated at sites with and without on-site availability of angiography

Archives of Internal Medicine

Volumn 162, Issue 5, 2002, Pages 553-559

  Pilote, Louise ^a   Lauzon, Claude ^b   Huynh, Thao ^a   Dion, Danielle ^c   Roux, René ^d   Racine, Normand ^e   Carignan, Suzanne ^f   Diodati, Jean G ^e   Lévesque, Claude ^g   Charbonneau, François ^a   Pouliot, Joël ^h   Joseph, Lawrence ^a   Eisenberg, Mark J ⁱ  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b Centre Hospitalier de la Région de l'Amiante   (Canada)

^c Centre Hospitalier Beauce Etchemin   (Canada)

^d Hôpital Sainte Croix de Drummondville   (Canada)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f Centre Hospitalier Régional du Grand Portage CSSS de Rivière du Loup   (Canada)

^g Complèxe Hospitalier de la Sagamie ^*  (Canada)

^h Centre Hospitalier de Val d'Or   (Canada)

ⁱ MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ANGINA PECTORIS; ANGIOGRAPHY; ARTICLE; CORONARY ARTERY BYPASS GRAFT; EMOTIONAL STABILITY; FEMALE; HEALTH CARE AVAILABILITY; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; QUALITY OF LIFE; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; WORK RESUMPTION;

EID: 0036187365     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.5.553     Document Type: Article

References (44)

1. Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction in the United States
2. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation
3. Management of patients with acute myocardial infarction at five academic medical centers
4. The association between on-site cardiac catheterization facilities and the utilization of coronary angiography after acute myocardial infarction
5. On-site catheterization laboratory and prognosis after acute myocardial infarction
6. Long-term outcome in acute myocardial infarction patients admitted to hospitals with and without on-site cardiac catheterization facilities
7. Outcomes of acute myocardial infarction in the Department of Veterans Affairs
8. Admission to hospitals with on-site cardiac catheterization facilities
9. Thrombolysis with tissue plasminogen activator in acute myocardial infarction
10. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction
11. Comparison of immediate invasive, delayed invasive and conservative strategies after tissue-type plasminogen activator results of the thrombolysis in myocardial infarction (TIMI) phase II-A trial
12. Randomized controlled trial of late inhospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction
13. SWIFT trial of delayed elective intervention vs conservative treatment after thrombolysis with anistreplase in acute myocardial infarction
14. One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) phase II trial
15. Two- and three-year results of the Thrombolysis in Myocardial Infarction (TIMI) phase II clinical trial
16. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial
17. One-year results of the Thrombolysis in Myocardial Infarction (TIMI IIIB) clinical trial
18. Outcomes in patients with acute nonQ-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy
19. Invasive compared with noninvasive treatment in unstable coronary-artery disease
20. Outcome at 1 year after an invasive compared with a noninvasive strategy in unstable coronary-artery disease: The FRISC II invasive randomised trial
21. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban
22. ACC/AHA guidelines for the management of patients with acute myocardial infarction
23. Medical resource and quality of life outcomes following acute myocardial infarction in Canada versus the United States: The Canadian-U.S. GUSTO substudy
24. The Medical Outcomes Study framework of health indicators
25. A critical appraisal of the quality of quality-of-life measurements
26. Cross-cultural adaptation of healthrelated quality of life measures
27. Measurement of health state utilities for economic appraisal: A review
28. Validity of EuroQol
29. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
30. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index)
31. Progress in the development of the index of ADL
32. Protocol for the bypass angiography revascularization investigation
33. Bayes factors
34. Treatment of acute myodcardial infarction in the United States and Canada
35. Higher rates of coronary angiography and revascularization following myocardial infarction may be associated with greater survival in the United States than in Canada
36. A comparison of management patterns after acute myocardial infarction in Canada and the United States
37. Use of cardiac procedures and outcomes in elderly patients with myocardial infarction in the United States and Canada
38. Management of unstable angina pectoris and non-Q-wave acute myocardial infarction in the United States and Canada (the TIMI III Registry)
39. Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial
40. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction